Literature DB >> 3885866

Risks and benefits of intensive treatment of acute leukaemia.

J M Chessells.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3885866      PMCID： PMC1777201          DOI： 10.1136/adc.60.3.193

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  15 in total

1.  Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.

Authors:  D R Miller; S Leikin; V Albo; H Sather; M Karon; D Hammond
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

Review 2.  Childhood acute lymphoblastic leukaemia: the late effects of treatment.

Authors:  J M Chessells
Journal:  Br J Haematol       Date:  1983-03       Impact factor: 6.998

Review 3.  The red cell membrane skeleton: recent progress.

Authors:  V T Marchesi
Journal:  Blood       Date:  1983-01       Impact factor: 22.113

4.  Short-term treatment for acute myelogenous leukaemia.

Authors:  R Bell; A Z Rohatiner; M L Slevin; J M Ford; H S Dhaliwal; G Henry; B G Birkhead; J A Amess; J S Malpas; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-24

5.  Isolated testicular relapse in boys with acute lymphoblastic leukaemia: treatment and outcome.

Authors:  J Tiedemann; J M Chessells; R M Sandland
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-04

Review 6.  Acute lymphoblastic leukemia.

Authors:  J M Chessells
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

7.  The treatment of acute myelocytic leukemia in patients 30 years of age and younger.

Authors:  H D Preisler; M Brecher; G Browman; A P Early; I R Walker; A Raza; A Freeman
Journal:  Am J Hematol       Date:  1982-11       Impact factor: 10.047

8.  Serious infections during continuing treatment of acute lymphoblastic leukaemia.

Authors:  J Ninane; J M Chessells
Journal:  Arch Dis Child       Date:  1981-11       Impact factor: 3.791

9.  Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.

Authors:  D R Miller; S Leikin; V Albo; L Vitale; H Sather; P Coccia; M Nesbit; M Karon; D Hammond
Journal:  Cancer Treat Rep       Date:  1980 Feb-Mar

10.  Marrow transplantation for children with acute nonlymphoblastic leukemia in first remission.

Authors:  J E Sanders; E D Thomas
Journal:  Med Pediatr Oncol       Date:  1981
View more
  1 in total

1.  Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).

Authors:  C R Pinkerton; A Bowman; H Holtzel; J M Chessells
Journal:  Arch Dis Child       Date:  1987-01       Impact factor: 3.791
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.